Vnitr Lek 2017, 63(9):566-571 | DOI: 10.36290/vnl.2017.114

Hypothyroidism in patients with heart disease

Jan Jiskra
III. interní klinika 1. LF UK a VFN v Praze

Hypothyroidism is frequently found in patients with heart disease. It is a risk factor for atherosclerosis and ischemic heart disease and has a direct negative effect on both the left and right ventricular functions (hypothyroidism-induced cardiomyopathy). The confirmed manifest hypothyroidism is always a reason for replacement therapy with levothyroxine; regarding patients with heart disease, we always begin treatment with a small dose and increase it gradually. The treatment of subclinical hypothyroidism in patients with heart disease is disputable and its benefits probably depend on age. At a higher age, the therapy-related risks often outweigh its benefits, so we make do with the target levels of the thyroid stimulating hormone being within the upper band of the normal range, or even slightly above it, rather than overdosing the patient. To summarize in a simplified way, the treatment of subclinical hypothyroidism in patients with heart disease is the most effective in younger individuals, mainly those aged below 65, while at a higher age > 80 years the risk usually outweighs the benefit.

Keywords: cardiovascular risk; hypothyroidism; ischemic heart disease; left ventricular dysfunction; right ventricular dysfunction; subclinical hypothyroidism; thyroid peroxidase antibodies

Received: June 27, 2017; Accepted: September 4, 2017; Published: September 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jiskra J. Hypothyroidism in patients with heart disease. Vnitr Lek. 2017;63(9):566-571. doi: 10.36290/vnl.2017.114.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Biondi B, Galderisi M, Pagano L et al. Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency. Eur J Endocrinol 2009; 161(2): 323-329. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-09-0196>. Go to original source... Go to PubMed...
    2. Abreu IM, Lau E, de Sousa Pinto B et al. Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile. Endocr Connect 2017; 6(3): 188-199. Dostupné z DOI: <http://dx.doi.org/10.1530/EC-17-0028>. Go to original source... Go to PubMed...
    3. Andersen MN, Olsen AM, Madsen JC et al. Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality. PLoS One 2015; 10(6): e0129793. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0129793>. Go to original source... Go to PubMed...
    4. Andersen MN, Olsen AS, Madsen JC et al. Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart Disease. J Clin Endocrinol Metab 2016; 101(11): 4170-4177. Go to original source... Go to PubMed...
    5. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011; 21(1): 5-11. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2010.0092>. Go to original source... Go to PubMed...
    6. Bremner AP, Feddema P, Leedman PJ et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97(5): 1554-1562. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011-3020>. Go to original source... Go to PubMed...
    7. Curotto Grasiosi J, Peressotti B, Machado RA et al. Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism. Endocrinol Nutr 2013; 60(8): 427-432. Dostupné z DOI: <http://dx.doi.org/10.1016/j.endonu.2013.01.013>. Go to original source...
    8. Franklyn JA. The thyroid - too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol (Oxf) 2013; 78(1): 1-8. Dostupné z DOI: <http://dx.doi.org/10.1111/cen.12011>. Go to original source... Go to PubMed...
    9. Garber JR, Cobin RH, Gharib H et al. [American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults]. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22(12): 1200-1235. Dostupné z DOI: <http://dx.doi.org/10.1089/thy.2012.0205>. Erratum in Thyroid 2013; 23(2): 251. Thyroid 2013; 23(1): 129. Go to original source... Go to PubMed...
    10. Hollowell JG, Staehling NW et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87(2): 489-499. Go to original source... Go to PubMed...
    11. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroidstimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the tromso Study. J Intern Med 2006; 260(1): 53-61. Go to original source... Go to PubMed...
    12. Mariotti S. Mild hypothyroidism and ischemic heart disease: Is age the answer? J Clin Endocrinol Metab 2008; 93(8): 2969-2971. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2008-1237>. Go to original source... Go to PubMed...
    13. Monzani F, Di Bello V, Caraccio N et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2001; 86(3): 1110-1115. Go to original source... Go to PubMed...
    14. Nyirenda MJ, Clark DN, Finlayson AR et al. Thyroid disease and increased cardiovascular risk. Thyroid 2005; 15(7): 718-724. Go to original source... Go to PubMed...
    15. Ochs N, Auer R, Bauer DC et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008; 148(11): 832-845. Go to original source... Go to PubMed...
    16. Razvi S, Ingoe L, Keeka G et al. The beneficial effect of lthyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomised, crossover trial. J Clin Endocrinol Metab 2007; 92(5): 1715-1723. Go to original source... Go to PubMed...
    17. Roos A, Linn-Rasker SP, van Domburg R et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, bouble-blind trial. Arch Intern Med 2005; 165(15): 1714-1720. Go to original source... Go to PubMed...
    18. Shakoor SK, Aldibbiat A, Ingoe LE et al. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab 2010; 95(1): 319-322. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2009-1421>. Go to original source... Go to PubMed...
    19. Singer RB. Mortality in a complete 4year follow up of 85yearold residents of leiden, classified by serum level of thyrotropin and thyroxine. J Insur Med 2006; 38(1): 14-19. Go to PubMed...
    20. Somwaru LL, Rariy CM, Arnold AM et al. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012; 97(6): 1962-1969. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011-3047>. Go to original source... Go to PubMed...
    21. Turhan S, Tulunay C, Ozduman Cin M et al. Effects of thyroxine therapy on right ventricular systolic and diastolic function in patients with subclinical hypothyroidism: a study by pulsed wave tissue Doppler imaging. J Clin Endocrinol Metab 2006; 91(9): 3490-3493. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.